Paricalcitol Effects on Activities and Metabolism of Platelet Activating Factor and on Inflammatory Cytokines in Hemodialysis Patients

Vitamin D receptor agonist supplementation and suppression of inflammation may have advantage for all-cause mortality in hemodialysis patients

(2012) Tetsuya Ogawa et al.   Clinical and Experimental Nephrology

Vitamin D Status and Mortality Risk in CKD: A Meta-analysis of Prospective Studies

(2011) Stefan Pilz et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Shining D' light on chronic kidney disease: Mechanisms that may underpin the cardiovascular benefit of vitamin D

(2011) WILLIAM G PETCHEY et al.   NEPHROLOGY

In Vitro and In Vivo Effects of Statins on Platelet-Activating Factor and Its Metabolism

(2010) Nektaria Tsantila et al.   ANGIOLOGY

Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression

(2010) N. Agmon-Levin et al.   ANNALS OF THE RHEUMATIC DISEASES

Cholecalciferol Supplementation Alters Calcitriol-Responsive Monocyte Proteins and Decreases Inflammatory Cytokines in ESRD

(2009) J. R. Stubbs et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Anti-Platelet-Activating Factor Effects of Highly Active Antiretroviral Therapy (HAART): A New Insight in the Drug Therapy of HIV Infection?

(2008) Alexandros B. Tsoupras et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure

(2008) Paraskevi Detopoulou et al.   CLINICAL BIOCHEMISTRY

Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease

(2008) Douglas M. Silverstein   PEDIATRIC NEPHROLOGY